Endothelial cells and pericytes play critical role in angiogenesis, which is controlled, in part, by the angiopoietin (Ang)/Tie-2 system and vascular endothelial growth factor (VEGF). Here, we investigated Ang, Tie-2, and VEGF expression within endothelial cells and pericyte interdigitations (EPI), which consist of cytoplasmic projections of pericytes and corresponding endothelial indentations. After subcutaneous implantation of a thermoreversible gelation polymer disc in rats, the capillary density was low on day 5, increased to a peak on day 7, and then decreased on days 10-20. A small number of EPI were observed on day 5, then increased sharply to a peak on day 10, but had decreased on day 20. Light and electron microscopy immunohistochemical and RNA in situ hybridization analyses revealed that Tie-2 localized at endothelial cells, and Ang-2 localized at endothelial cells and pericytes, while Ang-1 and VEGF localized at pericytes, and Ang-1 was most intensely observed at EPI of pericytes. Conventional quantitative RT-PCR and Western blot analyses revealed that the level of Ang-1 was low on days 5-7, then increased on days 10-20, while the level of VEGF was high on days 5-10, but had decreased on day 20. The level of Ang-2 remained high and Tie-2 remained at the level of the control on days 5-20. The present study showed that the angiogenic phase might be initiated by increases in Ang-2 and VEGF, while the microvessel maturation phase might be initiated by a relative increase in Ang-1 and a decrease in VEGF. Moreover, EPI might serve as a pathway for the Ang-1/Tie-2 system, with VEGF promoting pericyte recruitment for microvascular integrity.
Angiogenesis, the growth of new vessels from preexisting blood vessels, requires complex multistep signaling pathways and a high degree of spatial and temporal coordination among endothelial cells and pericytes. The precise mechanisms at the cellular and molecular levels are not completely defined. 1, 2 Despite their recognized importance in angiogenesis, pericytes have received less attention than endothelial cells, and their functions are only now beginning to be understood. [3] [4] [5] [6] [7] Pericytes share the basement membrane with endothelial cells and come into contact with them through holes in the basement membrane. Large numbers of ultrastructural endothelial cell and pericyte cytoplasmic interdigitations (EPI) are frequently demonstrated in angiogenic sites of human and murine tissues. [8] [9] [10] [11] [12] [13] [14] [15] These consist of a combination of pericyte cytoplasmic projections and corresponding indentations in the adjacent endothelial cells. [8] [9] [10] [11] [12] [13] [14] [15] In EPI, there is a distinctive gap measuring from 15 to 30 nm in width between endothelial cells and pericytes. 8, 9, 14 While it has been suggested that EPI might be a mechanical anchoring system for the two cells, [16] [17] [18] we have shown that the intercellular EPI space lacks adhesive glycoproteins, including fibronectin and laminin. 9, 11 Moreover, we have shown that plasmalemmal pits and vesicles are frequently present in the endothelial cells at EPI, 9 and have demonstrated that epidermal growth factor, 12 transforming growth factor-beta, plasminogen, and urokinase plasminogen activator are present in the intercellular EPI space. 19 The intercellular signaling mechanisms that govern the formation of blood vessels have only recently begun to be studied at the molecular level. Many growth factors are proposed to play a role in angiogenesis. Two types of vascular regulatory molecules that have been the subject of intense investigation in both physiological and pathological blood vessel generation are the angiopoietin (Ang)/ Tie-2 system and vascular endothelial growth factor (VEGF). [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Tie-2 is one of the receptor tyrosine kinases that are expressed by vascular endothelial cells, 21, 31, 32 and Ang-1 and -2, the ligands for Tie-2, have been reported to be important in the development of microvessels. [33] [34] [35] Ang-1 induces the autophosphorylation of Tie-2 in cultured endothelial cells, 22 and it has been proposed that Ang-1 recruits pericytes and potentiates microvessel stabilization and maturation by supporting interactions between endothelial cells and pericytes; however, the detailed biological character of pericytes is unclear. [33] [34] [35] [36] Ang-2 acts as an antagonist and inhibits Ang-1-induced phosphorylation of Tie-2 receptors in endothelial cells; as a result, Ang-2 initiates extensive angiogenesis resulting in pericyte drop-off and vascular destabilization. [22] [23] [24] [25] 29, 33, [37] [38] [39] The nature of cell-cell interactions such as EPI that occur during vessel formation and their mediators is difficult to discern from in vivo studies. Based on the distinct functions of Ang-1 and -2, we hypothesized that EPI are involved in the Ang/Tie2 system at angiogenic sites. In the present study, as an initial step toward the goal of understanding angiogenesis, we examined the formation of EPI, and the expression and localization of Ang-1, -2, Tie-2, and VEGF in rats subcutaneously implanted with a thermoreversible gelation polymer (TGP) disc, a three-dimensional culture medium gel 40 angiogenic disc model. The present study gives the first indication that Ang-1 may play a role in EPI by recruiting pericytes to support the primitive endothelial tubule and enhance microvessel maturation.
Materials and methods

Experimental Model
Forty male 7-week-old Sprague-Dawley (slc) rats (Japan SLC, Shizuoka, Japan) were housed, two per plastic cage, on hardwood-chip bedding in an environment-controlled room on a 12-h light/12-h dark cycle at 22721C and 5575% relative humidity with a conventional diet (MF, Oriental Yeast, Tokyo, Japan). All experimental procedures were conducted following approval of the Animal Care and Use Committee of the Azabu University School of Veterinary Medicine. Guidelines set by the National Institute of Health and Public Health Service Policy on the Humane Use and Care of Laboratory Animals were followed at all times. We used TGP (Mebiol Inc., Kanagawa, Japan) without additional any growth factors for the experimental angiogenic model. 40 TGP is a thermoreversible hydrogel comprising a copolymer of poly(N-isopropylacrylamide) and poly(ethylene glycol). 41, 42 The sterilized TGP discs were cut into circles measuring 14 mm in diameter and 2 mm in thickness, and were implanted subcutaneously in the rat through a far away skin incision. The discs were removed from 10 rats each 5, 7, 10, and 20 days after implantation and examined.
Electron Microscopy
Specimens were fixed in 0.1 M phosphate-buffered 1.2% glutaraldehyde for 2 h and then postfixed in 1.0% osmium tetroxide for 2 h. After dehydration in graded alcohols, the specimens were embedded in Epon 812. Thin sections were cut on a Porter-Blum MT-II ultramicrotome and mounted on formvarcoated slit grids. After double staining with uranyl acetate and lead citrate, the sections were observed with a Hitachi H-500H electron microscope. In order to limit our studies to newly formed capillaries within each sample, only the centers of the discs were sampled. The morphometry of cross-sectioned vessels was analyzed, and those having a length-towidth ratio of less than two were used.
14 Ten to 20 blood capillaries (not larger than 15 mm diameter, following the description by Leeson et al) 43 were photographed randomly from each of 10 different specimen blocks from each disc. The number of EPI per capillary, the number of capillaries per 1 mm 2 , the outer diameters of the capillaries, and the number of endothelial cells and pericytes per capillary on the electron micrographs were counted. The number of nuclei defined the endothelial cells and pericytes.
Immunohistochemistry for Light Microscopy
Immunohistochemical expressions of Ang-1, -2, Tie-2, and VEGF were analyzed using the avidin-biotin complex (ABC) method. After deparaffinization, 4-mm-thick sections were treated sequentially with 0.3% H 2 O 2 for 10 min, then blocked with 10% goat serum or rabbit serum in PBS for 20 min. Frozen sections were thawed, rinsed in PBS, and treated with primary antibodies of Ang-1 (N-18) sc-6319 goat polyclonal IgG (Santa Cruz Biotech, CA, USA; diluted 1:500), Ang-2 (F-18) sc-7017 goat polyclonal IgG (Santa Cruz Biotech; diluted 1:500), Tie-2 (H-167) sc-9026 rabbit polyclonal IgG (Santa Cruz Biotech; diluted 1:500), or VEGF (147) sc-507 rabbit polyclonal IgG (Santa Cruz Biotech; diluted 1:500). Bound IgG was detected with biotinylated goat antigoat IgG (Vector Lab., CA, USA; diluted 1:100) or anti-rabbit IgG (Vector Lab.; diluted 1:100), followed Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al by ABC-peroxidase (Vector Lab.) and diaminobenzidine (Sigma-Aldrich, MO, USA). Sections were then counterstained with hematoxylin. As a negative control, nonimmunized rabbit serum was substituted for the primary antibody.
Immunohistochemistry for Electron Microcopy
An indirect enzyme immunohistochemical of preembedded method was used. 44 Specimens were fixed in PLP solution 44 for 6 h, washed in graded sucrose solutions in 0.1 M phosphate-buffered saline, and frozen. Frozen sections were cut on a cryostat at a thickness of 6 mm and mounted on PLLcoated glass slides. The sections were incubated at 41C in a humidified chamber for 12 h with a primary antibody for Ang-1 (N-18) 0 -diaminobenzidine tetrahydrochloride (DAB) containing 0.1 M sodium azide and 0.005% hydrogen peroxidase for 3-6 min. A control section was stained using rabbit or goat preimmune serum without the corresponding primary antibody and processed as described above. For electron microscopy, sections were postfixed with 1.0% osmium tetroxide for 1 h and embedded in Epon 812. Ultrathin sections were cut on a Porter-Blum ultramicrotome and were mounted on Formvar-coated slit grids. The sections were observed with a Hitachi H-2000 electron microscope without uranyl acetate and lead citrate staining.
RNA In Situ Hybridization mRNA detection was used to prepare digoxigenin (DIG)-labeled antisense and sense probes. DIGlabeled sense probes were used as a negative control. Frozen sections were cut at a thickness of 10 mm on a cryostat, fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), and permeabilized with 0.01 M sodium citrate and 0.2 M HCl for 30 min, phosphate-buffered 1% sodium dodecyl sulfate (SDS) for 5 min, 1 mg/ml proteinase K for 30 min at 371C, and acetylated with 0.1 M triethanolamine containing 0.25% (v/v) acetic anhydride. Sections were incubated in hybridization solution, consisting of 1 Â Denhardt's solution, 2 Â SSC, 10% dextran sulfate, 50% formamide, 50 mg/ml yeast tRNA, 1 M DTT, and 1 mg/ml salmon sperm DNA for 16 h at 551C. After hybridization, sections were rinsed in 2 Â SSC at room temperature, then sequentially washed in 2 Â SSC/50% formamide at 551C, rinsed in 2 Â SSC at 371C, washed twice in 2 Â SSC/50% formamide at 551C, and washed three times in 2 Â SSC at room temperature. For signal amplification, a horseradish peroxidase-conjugated rabbit anti-digoxigenin antibody (Dako, CA, USA) was used to catalyze the deposition of biotinyltyramide, followed by a secondary streptavidin complex Gen Point kit (Dako). The final signal was visualized by incubation with DAB and 0.03% (v/v) hydrogen peroxide in 0.05 M Tris-HCl for 20 min, and the sections were counterstained in hematoxylin for 5 s. Antisense probes used for in situ hybridization were Ang-1 (
, and VEGF (5 0 -TGCGCTGGTAGACGT CCATGAACTTCACCACTTCATGGGCTTTCTGCT-3 0 ); these antisense sequences were complementary to nucleotide mRNA specific to rat. 45 Probes were chemically synthesized by and DIG-labeled oligonucleotide was obtained from Sigma Genosys (Sigma-Aldrich).
RNA Isolation
Total RNA was extracted from frozen tissue using a QIA shredding homogenizer and a Qiagen Rneasy Mini Kit (Qiagen Inc., CA, USA). After isolation, the quality of RNA samples was assessed using an Agilent 2100 bioanalyzer (Agilent Technologies Inc., CA, USA) and a RNA 6000 LabChip kit (Agilent Technologies Inc).
Semiquantitative RT-PCR
cDNA synthesis was performed using random hexamers with the Super Script First-Strand Synthesis kit according to the instructions of the manufacturer (Invitrogen Co., CA, USA). Then, 1 ml of the reverse transcription reaction was used for PCR amplification in a volume of 50 ml containing genespecific primers for Ang-1, Ang-2, VEGF, Tie-2, and GAPDH. Aliquots of the PCR reaction were removed at different cycles for agarose gel analysis to determine the linear range of amplification. All reactions were run on 2% agarose gel. The following primers were used: Ang-1 (GenBank AB080023) (fw:
. PCR was performed using a 9700 GeneAmp (Applied Biosystems, CA, USA) at 941C for 5 min, followed by 28 cycles of 941C for 1 min, 581C for 1 min, 721C for 1 min, and finally 721C for 7 min. PCR products were visualized on 2% agarose gels stained with ethidium bromide. Relative mRNA levels were compared with the corresponding levels of GADPH.
Quantitative RT-PCR
Real-time RT-PCR reactions were carried out using the cDNA equivalent of 100 ng total RNA for each sample in a total volume of 25 ml of TaqMan Universal PCR Master Mix (Applied Biosystems). The thermal cycling program for PCR was 501C for 2 min, 951C for 10 min, and 40 cycles of amplification comprising 951C for 15 s, and 601C for 1 min. PCR assay was performed using Assays on Demand Gene Expression Products in an ABI Prism 7700 sequence detector (Applied Biosystems). Gene expressions of Ang-2 (Rn01756774_m1), Tie-2 (Rn01433337_m1), and VEGF (Rn01511607_m1) (Applied Biosystems) were assayed. As a gene expression assay for Ang-1 has not been developed for Assays on Demand (Applied Biosystems), we applied a TaqMan rodent Ang-1 assay using the primers (fw:
The GAPDH primer was obtained from TaqMan rodent control reagents (Applied Biosystems). Amplification of GAPDH mRNA was performed as the internal gene control to account for variations in RNA levels between different samples. Data were collected and analyzed with Sequence detector v.1.7. The relative quantification method of DDC T was used as described in the manufacturer's manual (User Bulletin #2; P/N 4303859, pp 35). 47 Moreover, normal subcutaneous tissue was designated as the calibrator, and the normalized target gene values were compared to the calibration value according to the manufacturer's instructions for quantification of relative gene expression (User Bulletin #2; P/N 4303859, pp 15, 34). 48 
Western Blot Analysis
Specimens were homogenized in 50 mM Tris-HCl, 150 mM KCl (pH 7.4), 1% Triton X-100, and 0.25 mM phenylmethylsulfonyl fluoride and centrifuged at 8000 g for 30 min at 41C. The pellet was lysed with lysis buffer (10 mM Tris-HCl, 1% SDS, 1 mM EDTA, 10% glycerol, and 5% 2-mercaptoethanol. The protein concentrations of these lysates were quantified using 4 ml in a Protein 200 Lab-chip kit (Agilent Technologies Inc.) and run on an Agilent 2100 Bioanalyzer (Agilent Technologies Inc.). An equal amount of protein (10 mg) from each lysate was resolved on 10% SDS polyacrylamide gels under denaturing conditions and then transferred to Immuno-Blot polyvinylidene difluoride (PVDF) membranes (Bio-Rad Lab., CA, USA). After overnight blocking by immersion in 5% non-fat dried milk in phosphate-buffered saline with 0.1% (v/v) Tween 20 (PBS-T), Western blot analysis was performed using antibodies to Ang-1 (N-18) sc-6319 goat polyclonal IgG (Santa Cruz Biotech; diluted 1:1000), Ang-2 (F-18) sc-7017 goat polyclonal IgG (Santa Cruz Biotech; diluted 1:1500), Tie-2 (H-167) sc-9026 rabbit polyclonal IgG (Santa Cruz Biotech; diluted 1:2000), VEGF (147) sc-507 rabbit polyclonal IgG (Santa Cruz Biotech; diluted 1:1000), and beta-actin polyclonal IgG (Santa Cruz Biotech; diluted 1:4000) in PBS-T and incubated 1 h at room temperature on an orbital shaker. After being washed three times with PBS-T, the membranes were incubated with a 1:2500 dilution of peroxidase-conjugated goat IgG (ICN/Cappel Inc.) or peroxidase-conjugated rabbit IgG (ICN/Cappel Inc.) for 1 h on an orbital shaker. After being washed three times with PBS-T, the membranes were detected using the ECL Plus Western Blotting Detection System (Applied Biosystems). To verify the relative amounts of protein in each lane, the levels of beta-actin were determined as an internal control.
Statistical Analysis
For each data set, the mean value, s.d., and s.e.m. were calculated and compared by Scheffé's F-test using the statistical analysis program Stat View-J 5.0 (Abacus Concepts, NC, USA).
Results
General Characteristics of Newly Formed Capillaries in TGP Discs
Microvascular growth in the TGP disc proceeded in a centripetal direction. The angiogenic process was preceded by fibrovascular granulation tissues, consisting of capillary endothelial cells, pericytes, fibroblasts, and vacuolated fibroblasts, and was almost free from migrating inflammatory cells (Figures 1 and 2) .
On days 5-7, newly formed capillaries were morphologically composed of immature endothelial cells partially surrounded by pericytes (Figures 1  and 2 ). The cytoplasm of endothelial cells showed relative lucency with numerous free ribosomes, abundant intermediate filaments, a few rER, and a few mitochondria. The nuclei of the endothelial cells were large in comparison to the cytoplasm. These capillaries had relatively immature cell-tocell junctions near the lumen that form tight or gap junctions. The basement membrane was discontinuous. On day 10, more developed capillaries showing premature morphology were predominant (Figures 1 and 2 ). These had relatively large endothelial cells containing a greater amount of rER, well-developed Golgi complexes, many ovoid or spherical mitochondria, and abundant plasmalemmal pits and vesicles. The basement membrane was discontinuous to continuous. Mature capillaries were observed on days 10-20 (Figures 1 and 2 ). These capillaries consisted of a relatively thin wall of endothelial cells, and Golgi apparatus and cytoplasmic vesicles had increased proportionately to the cell volume. Degenerated capillaries were also observed on day 20 (Figures 1 and 2 ). These capillaries consisted of quite thin and twisting walls of endothelial cells with decreased rER.
In the various developmental stages of the newly formed capillaries, many EPI were observed. An EPI is a combination of a pericyte cytoplasmic projection and a corresponding endothelial cytoplasmic indentation; the intercellular spaces of EPI lacked a basement membrane and plasmalemmal pits and vesicles located at the endothelial indentation cell membrane (Figures 1 and 2) .
Quantification of EPI
The number of EPI per endothelial cell and pericyte was similar during the course of angiogenesis (Figure 3 ). The number of EPI per endothelial cell and pericyte was low on day 5, and comparable to those of normal subcutaneous tissue (control). The number of EPI per endothelial cell then gradually increased in the following days to reach a peak on day 10, when it was significantly higher than that of control. The number of EPI per pericyte also significantly increased on days 5-10 compared to that of control and reached a peak on day 10. The maximum number of EPI per endothelial cell and pericyte was about two to three times that of control. The number of EPI per endothelial cell and pericyte subsequently decreased and was similar to that of control by day 20 (Figure 3 ).
Quantitative Study of Density and Size of Newly Formed Capillaries
The number of capillaries per 1 mm 2 was taken as the capillary density. The capillary density was low on day 5, but it was significantly higher than that of control ( Figure 3) . After day 5, the capillary density increased sharply to reach a peak on day 7. The maximum values of the capillary density were about four to five times that of control. Then, the density showed a significant decline on days 10-20. The capillary density on day 20 was similar to that of control, but the density on other days was significantly higher than that of the control (Figure 3) . The outer diameter of the newly formed capillary was interpreted as the capillary size. Capillaries at days 5-7 were significantly smaller than those of control. Capillary size increased on days 10-20, and it was similar to that of control on day 20 ( Figure 3 ).
Quantification of Endothelial Cells and Pericytes
The numbers of endothelial cells and pericytes per capillary cross-section were counted. The numbers changed significantly during the course of angiogenesis. The change in the number of endothelial cells during angiogenesis was found to be the inverse of the change in the number of pericytes (Figure 3 ). Endothelial cell numbers on days 5-7 were similar to those of control. The endothelial cell number had significantly decreased by day 10, when it increased and on day 20 was similar to those of control ( Figure  3 ). The number of pericytes on days 5-7 was small and similar to those of control By day 10, the pericyte number had significantly increased, while it had decreased by day 20 and was similar to those of control (Figure 3) .
Localization of Ang-1, -2, Tie-2, and VEGF mRNA RNA in situ hybridization analysis revealed Ang-2 mRNA on the endothelial cell-and pericyte-like capillary walls (Figure 4 ). Tie-2 mRNA was observed on the endothelial cell-like luminal side of capillaries composed cells (Figure 4 ), while Ang-1 mRNA and VEGF mRNA were observed at pericyte-like perivascular mural cells (Figure 4) . To determine whether the localizations of Ang-1, -2, Tie-2, and VEGF mRNA correlated with the distribution of protein expression, immunohistochemical analysis was performed. Light and electron microscopy immunohistochemical analyses revealed that the expression of each protein was consistent with the pattern observed for each mRNA (Figures 5 and 6 ). Electron microscopy immunohistochemistry revealed that Ang-2 located at the cell membrane, plasmalemmal pits and vesicles, and cytoplasm of endothelial cells and pericytes of either immature or mature capillaries, and Tie-2 located at those of endothelial cells ( Figure 6 ). Although Ang-1 located at pericytes in both premature and mature capillaries, it was not observed in immature capillaries ( Figure 6 ). Moreover, Ang-1 was observed to localize intensely at the pericyte cytoplasmic projections of EPI and the cell membrane of the corresponding endothelial indentation including plasmalemmal pits and vesicles; localization was especially distinct on day 10 ( Figure 6 ). On the other hand, VEGF was located at the cell membrane and cytoplasm of pericytes ( Figure 6 ).
Ang-1, -2, Tie-2, and VEGF mRNA Expression in TGP Discs
The levels of Ang-1, -2, Tie-2, and VEGF mRNA expression were assessed by conventional and realtime quantitative RT-PCR. On days 5-7 after implantation, the expression of Ang-1 mRNA was significantly lower (0.4-to 0.5-fold) than that of control ( Figure 7 ). On day 10, Ang-1 mRNA had increased significantly (33-fold), and it had decreased (16-fold) by day 20, but both were significantly higher than that of control ( Figure 7 ). On days Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al 5-20 after implantation, the expression of Ang-2 mRNA maintained a significantly high level (12-to 15-fold) compared to that of control (Figure 8) , and the expression of Tie-2 mRNA maintained a low Figure 3 Time course of changes in EPI number, capillary density, capillary diameter, and number of endothelial cells and pericytes in TGF after subcutaneous implantation. 'control' indicates capillaries of normal (control) subcutaneous tissue. Values represent mean 7s.e.m. EPI counts per endothelial cell (a) and pericyte (b) after implantation. The peak number of EPI is observed on day 10 after implantation (a, b). The density of newly formed capillaries per mm 2 after implantation shows a peak on day 7 after implantation (c). The outer diameter (mm) of a newly formed capillary shows the peak on day 20 after implantation (d). Numbers of endothelial cells (e) and pericytes (f) after implantation. On day 10 after implantation, the number of endothelial cells decrease and that of pericytes increase (e, f). (**) Scheffé's F-test Po0.01. Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al level similar to that of control ( Figure 9 ). On days 5-7 after implantation, the expression of VEGF mRNA was significantly higher (28-to 30-fold) than that of control, and it reached a peak on day 10 (38-fold). The expression of VEGF mRNA had decreased sharply on day 20, when it was similar to that of control ( Figure 10 ). Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al
Ang-1, -2, Tie-2, and VEGF Protein Expression in TGP Discs
To determine whether the mRNA modulation of Ang-1, -2, Tie-2, and VEGF correlated with changes in protein expression, Western blotting was performed. The protein expression was qualitatively consistent with the patterns observed for each mRNA ( Figure 11 ).
Discussion
Constitutive expression of Ang-2 by normal tissue stabilizes existing blood vessels 38, 39 because the ratio of Ang-1 to Ang-2 appears to control the switch to microvessel remodeling. [49] [50] [51] Recently, it has been Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al reported that an equal amount of Ang-1 can rescue Ang-2-mediated effects, indicating that a balance between the two factors regulates the quiescence and responsiveness of microvessels. 52 The present study shows that the angiogenic phase might be initiated by increases in Ang-2 and VEGF, while the microvessel maturation phase might be initiated by a relative increase in Ang-1 and a decrease in VEGF. It has been postulated that the angiogenic process of the present TGP in vivo angiogenic model depends on a change in the Ang-1 level. Further studies will be designed to test this hypothesis directly.
In this study, Tie-2 was observed to localize at the cell membrane, plasmalemmal pits and vesicles, and cytoplasm of endothelial cells. These results agree with most of the literature published concerning this receptor system. 53, 54 Endothelial cells have been described as the primary source for Ang-2, suggesting that it might act as an autocrine regulator of endothelial cell functions, 23, [55] [56] [57] [58] [59] [60] [61] while in vitro data has suggested that Ang-2 expression increases in pericytes under hyperglycemic conditions. 61 The present in vivo study revealed that Ang-2 localized at endothelial cells and pericytes of both immature and mature microvessels, while in vitro studies have produced evidence consistent with the hypothesis that Ang-1 is produced by pericytes and smooth muscle cells, and might act in a paracrine manner for Tie-2-expressing endothelial cells. 22, 23, 55, 57, 62, 63 Whether pericytes express Ang-1 in vivo has been hard to demonstrate, but cell sorting experiments suggest they do. 64 Moreover, a recent study using in situ hybridization demonstrated Ang-1 mRNA expression by perivascular cells during microvessel maturation, but the limited resolution of light microscopy presented made it difficult to distinguish pericytes. 65 We also observed Ang-1 mRNA expression by pericyte-like perivascular mural cells by light microscopic in situ hybridization, while the present study using electron microscopy immunohistochemistry clearly revealed that pericytes were the primary source of Ang-1. Moreover, recent studies have shown that pericytes are induced to express VEGF, which might contribute to development of the microvessel itself. 7, 64, [66] [67] [68] [69] [70] In this study, it was clearly shown by electron microscopy immunohistochemistry that pericytes express VEGF.
EPI are sites of intimate contact between pericytes and endothelial cells by interdigitation. [8] [9] [10] We have shown in the present study and a previous report that EPI are predominate following the active microvessel proliferation stage in the angiogenic process.
14 Physical contact between pericytes and endothelial cells has been reported to be necessary to prevent angiogenesis with inhibition of endothelial cell proliferation. 3, 4, 71, 72 Further, we have demonstrated that EPIs acting as a pathway for the EGF/EGF-receptor system might activate pericytes for capillary maturation. 12, 13 We have also reported that EPI activation of latent TGF-beta might inhibit endothelial cell proliferation, and promote capillary maturation and degeneration. 19 It has been reported that reduced expression of VEGF and enhanced expression of Ang-1 might contribute to the formation of leakage-resistant blood vessels. 34, 73 Recently, we demonstrated that the direct injection of an antibody neutralizing VEGF induces a significant decrease in the number of EPI and an increase in the number of nonleaky capillaries in an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinoma model. 15 EPI have been difficult structures to study by light microscopy. The present study revealed that Ang-1 is expressed ultrastructurally by pericytes, especially at the pericyte cytoplasmic projections of EPI and cell membranes of the Figure 11 Western blots of Ang-1, -2, Tie-2, and VEGF in TGF after subcutaneous implantation. (a) Shows representative Western blot bands, and (b) shows the density ratio to beta-actin; results were obtained by screening samples from five rats on each day. Values represent mean 7s.d.
Ang-1, -2, Tie-2 and VEGF at EPI S Wakui et al corresponding endothelial indentation. As Ang-1 and Tie-2 appear to be required for communication of endothelial cells with pericytes, EPI might, in part, act as a pathway for the Ang-1/Tie-2 system to stabilize microvessels.
